Talk:Insulin icodec
 | This article is rated Stub-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||
| |||||||||||
Request for text change
edit"under the brand name Aweeqli (incorrect information posted by original author)" should be deleted. Same with ”Aweeqli” from Trade Names under the Clinical data section to the right. Reason being that there is no brand name/trade name for insulin icodec as it is an investigational drug with not regulatory approval in any market. — Preceding unsigned comment added by 213.32.242.248 (talk) 12:59, 23 August 2023 (UTC)
Need a second opinion
editDear DGG, do we consider Wikipedia pages for the under-trial drugs? If yes, then what are the judging criteria. -Hatchens (talk) 06:13, 29 April 2022 (UTC)
Removal request
edit | The Wikimedia Foundation's Terms of Use require that editors disclose their "employer, client, and affiliation" with respect to any paid contribution; see WP:PAID. For advice about reviewing paid contributions, see WP:COIRESPONSE.
|
 | This edit request by an editor with a conflict of interest has now been answered. |
On behalf of Novo Nordisk via Burson Cohn & Wolfe, and as part of my work at Beutler Ink, I'd like to submit an edit request to remove the text "under the brand name Aweeqli (incorrect information posted by original author)" from the introduction, as well as "Aweeqli" from the "Trade names" field in the infobox. Recent changes to the article show multiple attempts to add mention of Aweeqli, despite no evidence in reliable sources. A search for "Aweeqli" at Google News yields zero results, and I see a similar request has already been posted above. I will let editors decide if some sort of page protection might be helpful, but in the meantime I propose removing the disputed content. Thanks! Inkian Jason (talk) 21:18, 28 August 2023 (UTC)
- I have removed the unsourced and WP:CHALLENGED information. WhatamIdoing (talk) 02:08, 29 August 2023 (UTC)